VC-backed Bolt Biotherapeutics debuts IPO
Bolt Biotherapeutics Inc has gone public after pricing its 11.5 million shares at $20 per share.
Bolt Biotherapeutics Inc has gone public after pricing its 11.5 million shares at $20 per share.
Copyright PEI Media
Not for publication, email or dissemination